These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38167037)

  • 1. Clinical impact of ampulla of Vater cancer subtype classification based on immunohistochemical staining.
    Kwon CH; Ahn JH; Seo HI; Kim DU; Han SY; Kim S; Lee NK; Hong SB; Park YM; Noh BG
    World J Surg Oncol; 2024 Jan; 22(1):5. PubMed ID: 38167037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance].
    Liu FF; Shen DH; Wang HL; Ma YT; Yuan F; Liu J; Chen L; Song QJ; Zhang YY
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):92-97. PubMed ID: 30695858
    [No Abstract]   [Full Text] [Related]  

  • 3. The utility of immunohistochemistry in subtyping adenocarcinoma of the ampulla of vater.
    Ang DC; Shia J; Tang LH; Katabi N; Klimstra DS
    Am J Surg Pathol; 2014 Oct; 38(10):1371-9. PubMed ID: 24832159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of CK7, CK20, CDX2 in intestinal and pancreatobiliary types of preriampullary carcinoma.
    Sree UD; Prayaga AK; R Reddy VV; Rukmanghadha N; Chowhan AK; Phaneendra BV
    Indian J Pathol Microbiol; 2022; 65(1):42-48. PubMed ID: 35074964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
    Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
    Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of immunohistochemical expression of CK7 and CK20 in curatively resected ampulla of Vater cancer.
    Yun SP; Seo HI
    BMC Gastroenterol; 2015 Nov; 15():165. PubMed ID: 26603157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal and pancreatobiliary differentiation in periampullary carcinoma: the role of immunohistochemistry.
    Kumari N; Prabha K; Singh RK; Baitha DK; Krishnani N
    Hum Pathol; 2013 Oct; 44(10):2213-9. PubMed ID: 23834763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical Classification of Ampullary Carcinomas: Critical Reappraisal Fails to Confirm Prognostic Relevance for Recently Proposed Panels, and Highlights MUC5AC as a Strong Prognosticator.
    Xue Y; Reid MD; Balci S; Quigley B; Muraki T; Memis B; Xia J; Hacihasanoglu E; Bedolla G; Pehlivanoglu B; Kim GE; Tajiri T; Ohike N; Aneja R; Krasinskas AM; Adsay V
    Am J Surg Pathol; 2017 Jul; 41(7):865-876. PubMed ID: 28505002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical Predictors for Intestinal and Pancreatobiliary Types of Adenocarcinoma of The Ampulla of Vater.
    da Silveira Santos JPL; Machado CJ; Junior EP; Rodrigues JBSR; Vidigal PT; Resende V
    J Gastrointest Surg; 2018 Jul; 22(7):1171-1178. PubMed ID: 29736668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of ampullary cancer based on immunohistochemical type and expression of osteopontin.
    Zhao XQ; Dong JH; Zhang WZ; Liu Z
    Diagn Pathol; 2011 Oct; 6():98. PubMed ID: 21992455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
    Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM
    Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can we classify ampullary tumours better? Clinical, pathological and molecular features. Results of an AGEO study.
    Perkins G; Svrcek M; Bouchet-Doumenq C; Voron T; Colussi O; Debove C; Merabtene F; Dumont S; Sauvanet A; Hammel P; Cros J; André T; Bachet JB; Bardier A; Douard R; Meatchi T; Peschaud F; Emile JF; Cojean-Zelek I; Laurent-Puig P; Taieb J
    Br J Cancer; 2019 Apr; 120(7):697-702. PubMed ID: 30837681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue microarray-chip featuring computerized immunophenotypical characterization more accurately subtypes ampullary adenocarcinoma than routine histology.
    Palmeri M; Funel N; Franco GD; Furbetta N; Gianardi D; Guadagni S; Bianchini M; Pollina LE; Ricci C; Chiaro MD; Candio GD; Morelli L
    World J Gastroenterol; 2020 Nov; 26(43):6822-6836. PubMed ID: 33268964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater.
    de Paiva Haddad LB; Patzina RA; Penteado S; Montagnini AL; da Cunha JE; Machado MC; Jukemura J
    J Gastrointest Surg; 2010 Apr; 14(4):719-28. PubMed ID: 20107918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation and prognostic markers in ampullary cancer: Role of p53, MDM2, CDX2, mucins and cytokeratins.
    Perysinakis I; Minaidou E; Mantas D; Sotiropoulos GC; Leontara V; Tsipras H; Zografos GN; Margaris I; Kouraklis G
    Pathol Res Pract; 2016 Nov; 212(11):1039-1047. PubMed ID: 27688085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of ampullary carcinoma mixed subtype using a panel of six antibodies and its clinical significance.
    Liu F; Shen D; Ma Y; Song Q; Wang H
    J Surg Oncol; 2019 Mar; 119(3):295-302. PubMed ID: 30548547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytokeratins 7 and 20 immunohistochemistry in ampullary carcinomas].
    Le Pessot F; Ranty ML; Hellot MF; Lemoine F; Ténière P; Testart J; Métayer J
    Ann Pathol; 2004 Sep; 24(4):312-8. PubMed ID: 15567946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma.
    Shin JH; Bae JH; Lee A; Jung CK; Yim HW; Park JS; Lee KY
    Jpn J Clin Oncol; 2010 Mar; 40(3):208-13. PubMed ID: 19926591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDX2, cytokeratins 7 and 20 immunoreactivity in rectal adenocarcinoma.
    Saad RS; Silverman JF; Khalifa MA; Rowsell C
    Appl Immunohistochem Mol Morphol; 2009 May; 17(3):196-201. PubMed ID: 19098678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histologic subtype-based evaluation of recurrence and survival outcomes in patients with adenocarcinoma of the ampulla of Vater.
    Park SJ; Shin K; Hong TH; Lee SH; Kim IH; Kim Y; Lee M
    Sci Rep; 2023 Oct; 13(1):16547. PubMed ID: 37783755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.